Page last updated: 2024-08-25

bromopyruvate and Carcinoma, Non-Small Cell Lung

bromopyruvate has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dai, K; Leonardi, D; Radin, DP	1
Kalyanaraman, B; Komas, SM; Lubet, RA; Pan, J; Wang, Y; You, M; Zhang, Q	1

Other Studies

2 other study(ies) available for bromopyruvate and Carcinoma, Non-Small Cell Lung

Article	Year
PINK1 depletion sensitizes non-small cell lung cancer to glycolytic inhibitor 3-bromopyruvate: Involvement of ROS and mitophagy. Pharmacological reports : PR, 2019, Volume: 71, Issue:6 Topics: A549 Cells; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Glycolysis; Humans; Lung; Lung Neoplasms; Mitochondria; Mitophagy; Parkinson Disease; Protein Kinases; Pyruvates; Reactive Oxygen Species; Signal Transduction; Ubiquitin-Protein Ligases	2019
Enhanced antitumor activity of 3-bromopyruvate in combination with rapamycin in vivo and in vitro. Cancer prevention research (Philadelphia, Pa.), 2015, Volume: 8, Issue:4 Topics: Adenosine Triphosphate; Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Energy Metabolism; Enzyme Inhibitors; Female; Glycolysis; Humans; Lung Neoplasms; Mice; Mice, Inbred A; Mitochondria; Oxygen Consumption; Pyruvates; Sirolimus; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2015

Article

Year

PINK1 depletion sensitizes non-small cell lung cancer to glycolytic inhibitor 3-bromopyruvate: Involvement of ROS and mitophagy.

Pharmacological reports : PR, 2019, Volume: 71, Issue:6

Topics: A549 Cells; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Glycolysis; Humans; Lung; Lung Neoplasms; Mitochondria; Mitophagy; Parkinson Disease; Protein Kinases; Pyruvates; Reactive Oxygen Species; Signal Transduction; Ubiquitin-Protein Ligases

2019

Enhanced antitumor activity of 3-bromopyruvate in combination with rapamycin in vivo and in vitro.

Cancer prevention research (Philadelphia, Pa.), 2015, Volume: 8, Issue:4

Topics: Adenosine Triphosphate; Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Energy Metabolism; Enzyme Inhibitors; Female; Glycolysis; Humans; Lung Neoplasms; Mice; Mice, Inbred A; Mitochondria; Oxygen Consumption; Pyruvates; Sirolimus; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2015